Results 31 to 40 of about 3,754,903 (381)

Cardiovascular Complications of SARS-CoV-2 Vaccines: An Overview

open access: yesCardiology and Therapy, 2021
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the deadly disease known as coronavirus disease 2019 (COVID-19) that has reached pandemic proportions.
Amirabbas Shiravi   +3 more
semanticscholar   +1 more source

Coronavirus disease 2019 and cardiovascular complications: focused clinical review

open access: yesJournal of Hypertension, 2021
The coronavirus disease 2019 (COVID-19) may cause not only an acute respiratory distress syndrome (ARDS) but also multiple organ damage and failure requiring intensive care and leading to death.
S. Saeed   +4 more
semanticscholar   +1 more source

Cardiovascular complications of SARS-CoV-2 infection (COVID-19): a systematic review and meta-analysis.

open access: yesReviews in cardiovascular medicine, 2021
Coronavirus Disease 2019 (COVID-19) originated in Wuhan, China in December 2019 and rapidly spread worldwide. Herein, we conducted a systematic review and meta-analysis to find the association between COVID-19 and cardiovascular complications.
Yuhao Zhao   +3 more
semanticscholar   +1 more source

HIV INFECTION AND CARDIOVASCULAR COMPLICATIONS

open access: yesKlinicist, 2014
Due to the increasing number of HIV-infected patients and duration of their survival value for cardiovascular disease complications in the structure of HIV is increasing.
S. S. Yakushin, E. V. Filippov
doaj   +3 more sources

The Role of Fibroblast Growth Factor 21 in Diabetic Cardiovascular Complications and Related Epigenetic Mechanisms

open access: yesFrontiers in Endocrinology, 2021
Fibroblast growth factor 21 (FGF21), is an emerging metabolic regulator mediates multiple beneficial effects in the treatment of metabolic disorders and related complications.
Mengjie Xiao   +7 more
doaj   +1 more source

Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms [PDF]

open access: yes, 2018
Hypertension and type 2 diabetes are common comorbidities. Hypertension is twice as frequent in patients with diabetes compared with those who do not have diabetes.
Guzik, Tomasz J.   +2 more
core   +1 more source

The ASA score predicts infections, cardiovascular complications, and hospital readmissions after hip fracture - A nationwide cohort study

open access: yesOsteoporosis International, 2021
This study examines the association between the ASA physical status classification score at hip fracture surgery and severe postoperative complications in patients aged 60 and older.
A. Meyer   +3 more
semanticscholar   +1 more source

Hemorheological Failure in the Pathology of Cardio-vascular Complications in Patients with Diabetic Foot Syndrome [PDF]

open access: yes, 2016
The literature that includes the study of cardiovascular complications in patients with diabetic foot syndrome was analyzed. The topicality of this problem is caused by the steady growth of diabetes mellitus morbidity among people.
Кorobko, Е. (Еlina)
core   +2 more sources

Racial Disparities in Cardiovascular Complications With Pregnancy-Induced Hypertension in the United States

open access: yesHYPERTENSION, 2021
Supplemental Digital Content is available in the text. Women with pregnancy-induced hypertension, defined as gestational hypertension and preeclampsia/eclampsia, are at increased risk of long-term cardiovascular disease, but less is known about the ...
Anum S. Minhas   +8 more
semanticscholar   +1 more source

Immunophilins and Cardiovascular Complications

open access: yesCurrent Medicinal Chemistry, 2011
Immunophilins belong to a highly conserved family of proteins with cis-trans peptidyl-prolyl isomerase activity, generally classified by their ability to selectively bind specific immunosuppressive drugs, thereby regulating their activity. Immunophilins include Cyclophilins (CyPs), which are specific targets of the immunosuppressant drug cyclosporin A (
Calderón-Sánchez, Eva   +2 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy